Debt-to-equity in % of Centessa Pharmaceuticals plc from Q1 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Centessa Pharmaceuticals plc quarterly Debt-to-equity history and growth rate from Q1 2022 to Q3 2025.
  • Centessa Pharmaceuticals plc Debt-to-equity for the quarter ending September 30, 2025 was 42.6 %, a 14.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

Centessa Pharmaceuticals plc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 42.6 +5.46 +14.7% Sep 30, 2025
Q2 2025 35.2 -11.6 -24.7% Jun 30, 2025
Q1 2025 34.3 -13.5 -28.2% Mar 31, 2025
Q4 2024 36.4 -7.6 -17.3% Dec 31, 2024
Q3 2024 37.1 -1.74 -4.48% Sep 30, 2024
Q2 2024 46.8 +12.3 +35.5% Jun 30, 2024
Q1 2024 47.7 +17.8 +59.3% Mar 31, 2024
Q4 2023 44 +18.1 +69.6% Dec 31, 2023
Q3 2023 38.9 +13.5 +53.3% Sep 30, 2023
Q2 2023 34.5 +13.7 +65.7% Jun 30, 2023
Q1 2023 30 +12.8 +74.7% Mar 31, 2023
Q4 2022 26 Dec 31, 2022
Q3 2022 25.4 Sep 30, 2022
Q2 2022 20.8 Jun 30, 2022
Q1 2022 17.2 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.